University of California, Davis, CA.
American Society of Clinical Oncology, Alexandria, VA.
J Clin Oncol. 2021 Mar 10;39(8):931-939. doi: 10.1200/JCO.20.03364. Epub 2021 Jan 27.
The American Society for Radiation Oncology (ASTRO) produced an evidence-based guideline on radiation therapy (RT) for small-cell lung cancer (SCLC). Because of the relevance of this topic to ASCO membership, ASCO reviewed the guideline, applying a set of procedures and policies used to critically examine guidelines developed by other organizations.
The ASTRO guideline on RT for SCLC was reviewed for developmental rigor by methodologists. Then, an ASCO Expert Panel reviewed the content and the recommendations.
The ASCO Expert Panel determined that the recommendations from ASTRO guideline on RT for SCLC, published in June 2020, are clear, thorough, and based upon the most relevant scientific evidence. ASCO endorsed ASTRO guideline on RT for SCLC with a few discussion points.
Recommendations addressed thoracic radiotherapy for limited-stage SCLC, role of stereotactic body radiotherapy in stage I or II node-negative SCLC, prophylactic cranial radiotherapy, and thoracic consolidation for extensive-stage SCLC.Additional information is available at www.asco.org/thoracic-cancer-guidelines.
美国放射肿瘤学会（ASTRO）制定了一份关于小细胞肺癌（SCLC）放射治疗（RT）的循证指南。由于该主题与 ASCO 会员相关，ASCO 对该指南进行了审查，应用了一组用于严格审查其他组织制定的指南的程序和政策。
方法学家对 SCLC 的 ASTRO 指南的制定方法进行了严格审查。然后，ASCO 专家组对内容和建议进行了审查。
ASCO 专家组确定，ASTRO 于 2020 年 6 月发布的 SCLC 放射治疗指南中的建议明确、全面，并基于最相关的科学证据。ASCO 对 SCLC 的 ASTRO 放射治疗指南表示认可，并附有一些讨论要点。
建议包括局限期 SCLC 的胸部放疗、立体定向体部放射治疗在 I 期或 II 期无淋巴结转移的 SCLC 中的作用、预防性颅放疗以及广泛期 SCLC 的胸部巩固治疗。更多信息可在 www.asco.org/thoracic-cancer-guidelines 上获取。
Zotero 插件